SDC1 and respiratory failure: Several other studies have also reported that an increased syndecan-1 concentration in the blood is associated with increased morbidity and mortality, including increased vasopressor use, acute kidney injury, and respiratory failure in patients undergoing surgery or in those with critical illness [6,10,11,12].